-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Maintains Buy on MBX Biosciences, Raises Price Target to $88

Benzinga·01/16/2026 15:17:17
Listen to the news
Guggenheim analyst Seamus Fernandez maintains MBX Biosciences (NASDAQ:MBX) with a Buy and raises the price target from $77 to $88.